Zobrazeno 1 - 10
of 506
pro vyhledávání: '"Barbara, Seliger"'
Autor:
Meron Yohannes, Zelalem Desalegn, Marcus Bauer, Kathrin Stückrath, Endale Anberbir, Yonas Bekuretsion, Mathewos Assefa, Tariku Wakuma, Yasin Worku, Pablo S. C. Santos, Lesley Taylor, Adamu Adissie, Claudia Wickenhauser, Chiara Massa, Martina Vetter, Eva Johanna Kantelhardt, Barbara Seliger, Tamrat Abebe
Publikováno v:
Breast Cancer Research, Vol 26, Iss 1, Pp 1-13 (2024)
Abstract Background The clinical management of breast cancer (BC) is mainly based on the assessment of receptor expression by tumour cells. However, there is still an unmet need for novel biomarkers important for prognosis and therapy. The tumour imm
Externí odkaz:
https://doaj.org/article/c816e041d2234f6cb299e121c841ba01
Autor:
Meron Yohannes, Chiara Massa, Zelalem Desalegn, Kathrin Stückrath, Anja Mueller, Endale Anberber, Yonas Bekuretsion, Mathewos Assefa, Pablo Santos, Adamu Addissie, Marcus Bauer, Claudia Wickenhauser, Lesley Taylor, Martina Vetter, Eva Johanna Kantelhardt, Tamrat Abebe, Barbara Seliger
Publikováno v:
OncoImmunology, Vol 13, Iss 1 (2024)
Breast cancer (BC) is a leading cause of death worldwide, particularly also among African woman. In order to better stratify patients for the most effective (immuno-) therapy, an in depth characterization of the immune status of BC patients is requir
Externí odkaz:
https://doaj.org/article/45dbd50e44934629a48b0b7f0fa9761a
Autor:
Yuan Wang, Barbara Seliger
Publikováno v:
OncoImmunology, Vol 13, Iss 1 (2024)
Deregulation or loss of the human leukocyte antigen class I (HLA-I) molecules on tumor cells leading to inhibition of CD8+ T cell recognition is an important tumor immune escape strategy, which could be caused by a posttranscriptional control of mole
Externí odkaz:
https://doaj.org/article/9cbec6a5f39444e69be06d5bacfdd2b2
Autor:
Marcus Bauer, Nadja Jäkel, Andreas Wilfer, Anja Haak, Markus Eszlinger, Katalin Kelemen, Monika Haemmerle, Haifa Kathrin Al-Ali, Barbara Seliger, Claudia Wickenhauser
Publikováno v:
OncoImmunology, Vol 13, Iss 1 (2024)
Genetic aberrations and immune escape are fundamental in MDS and CMML initiation and progression to sAML. Therefore, quantitative and spatial immune cell organization, expression of immune checkpoints (ICP), classical human leukocyte antigen class I
Externí odkaz:
https://doaj.org/article/d789636c13bc4b76ba0c87d2a1cef791
Autor:
Yuan Wang, Maria‐Filothei Lazaridou, Theresa Kordaß, Chiara Massa, Christoforos K. Vaxevanis, Stefan Eichmüller, Barbara Seliger
Publikováno v:
Clinical and Translational Medicine, Vol 14, Iss 10, Pp n/a-n/a (2024)
Externí odkaz:
https://doaj.org/article/02d177d537704a2cb9d29cf483312faf
Autor:
Annalena Branz, Christian Matek, Fabienne Lange, Veronika Bahlinger, Niklas Klümper, Michael Hölzel, Pamela L. Strissel, Reiner Strick, Danijel Sikic, Sven Wach, Helge Taubert, Bernd Wullich, Arndt Hartmann, Barbara Seliger, Markus Eckstein
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionUrothelial bladder cancer is frequent and exhibits diverse prognoses influenced by molecular subtypes, urothelial subtype histology, and immune microenvironments. HLA-G, known for immune regulation, displays significant membranous express
Externí odkaz:
https://doaj.org/article/9a3359d7262e4505b637932af7440aae
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 8 (2024)
The importance of the immune system in regulating tumor growth by inducing immune cell-mediated cytotoxicity associated with patients’ outcomes has been highlighted in the past years by an increasing life expectancy in patients with cancer on treat
Externí odkaz:
https://doaj.org/article/678ae7a2ef5e4297af8ae6150c60b7c5
Autor:
Marcus Bauer, Astrid Monecke, Hubert Hackl, Andreas Wilfer, Nadja Jaekel, Hendrik Bläker, Haifa Kathrin Al-Ali, Barbara Seliger, Claudia Wickenhauser
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionMyeloid sarcomas (MS) comprise rare extramedullary manifestations of myeloid neoplasms with poor patients’ outcome. While the clinical relevance of the tumor microenvironment (TME) is well established in many malignancies, there exists
Externí odkaz:
https://doaj.org/article/d57c7228eeb94e96aa3ee37df368358a
Deciphering the role of alternative splicing in neoplastic diseases for immune-oncological therapies
Autor:
Marcus Bauer, Chiara-Maria Schöbel, Claudia Wickenhauser, Barbara Seliger, Simon Jasinski-Bergner
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Alternative splicing (AS) is an important molecular biological mechanism regulated by complex mechanisms involving a plethora of cis and trans-acting elements. Furthermore, AS is tissue specific and altered in various pathologies, including infectiou
Externí odkaz:
https://doaj.org/article/aab3201227004887b53157dbecf5af16
Autor:
Chiara Massa, Thomas Karn, Karsten Weber, Andreas Schneeweiss, Claus Hanusch, Jens Uwe Blohmer, Dirk‐Michael Zahm, Christian Jackisch, Marion van Mackelenbergh, Jörg Thomalla, Frederik Marmé, Jens Huober, Volkmar Müller, Christian Schem, Anja Müller, Elmar Stickeler, Katharina Biehl, Peter A. Fasching, Michael Untch, Sibylle Loibl, Carsten Denkert, Barbara Seliger
Publikováno v:
Clinical and Translational Medicine, Vol 14, Iss 4, Pp n/a-n/a (2024)
Externí odkaz:
https://doaj.org/article/f921f7466a0a4b568dfafa8ea0d35cf6